Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SHE:301211)
China flag China · Delayed Price · Currency is CNY
12.76
+0.02 (0.16%)
Feb 4, 2026, 12:05 PM CST

SHE:301211 Statistics

Total Valuation

SHE:301211 has a market cap or net worth of CNY 5.32 billion. The enterprise value is 3.75 billion.

Market Cap5.32B
Enterprise Value 3.75B

Important Dates

The next estimated earnings date is Tuesday, March 31, 2026.

Earnings Date Mar 31, 2026
Ex-Dividend Date May 26, 2025

Share Statistics

SHE:301211 has 417.60 million shares outstanding. The number of shares has increased by 0.56% in one year.

Current Share Class 417.60M
Shares Outstanding 417.60M
Shares Change (YoY) +0.56%
Shares Change (QoQ) -31.01%
Owned by Insiders (%) 12.00%
Owned by Institutions (%) 0.04%
Float 176.44M

Valuation Ratios

The trailing PE ratio is 140.71.

PE Ratio 140.71
Forward PE n/a
PS Ratio 12.35
PB Ratio 2.35
P/TBV Ratio 2.43
P/FCF Ratio n/a
P/OCF Ratio 80.63
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 144.18, with an EV/FCF ratio of -173.66.

EV / Earnings 99.23
EV / Sales 8.71
EV / EBITDA 144.18
EV / EBIT n/a
EV / FCF -173.66

Financial Position

The company has a current ratio of 13.95, with a Debt / Equity ratio of 0.00.

Current Ratio 13.95
Quick Ratio 12.79
Debt / Equity 0.00
Debt / EBITDA 0.12
Debt / FCF -0.14
Interest Coverage -8.60

Financial Efficiency

Return on equity (ROE) is 1.66% and return on invested capital (ROIC) is -0.30%.

Return on Equity (ROE) 1.66%
Return on Assets (ROA) -0.06%
Return on Invested Capital (ROIC) -0.30%
Return on Capital Employed (ROCE) -0.10%
Weighted Average Cost of Capital (WACC) 8.81%
Revenue Per Employee 436,441
Profits Per Employee 38,317
Employee Count987
Asset Turnover 0.18
Inventory Turnover 2.44

Taxes

In the past 12 months, SHE:301211 has paid 3.14 million in taxes.

Income Tax 3.14M
Effective Tax Rate 7.66%

Stock Price Statistics

The stock price has increased by +8.41% in the last 52 weeks. The beta is 0.83, so SHE:301211's price volatility has been lower than the market average.

Beta (5Y) 0.83
52-Week Price Change +8.41%
50-Day Moving Average 13.26
200-Day Moving Average 12.80
Relative Strength Index (RSI) 46.72
Average Volume (20 Days) 10,201,015

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, SHE:301211 had revenue of CNY 430.77 million and earned 37.82 million in profits. Earnings per share was 0.09.

Revenue430.77M
Gross Profit 92.59M
Operating Income -2.26M
Pretax Income 40.96M
Net Income 37.82M
EBITDA 24.64M
EBIT -2.26M
Earnings Per Share (EPS) 0.09
Full Income Statement

Balance Sheet

The company has 1.57 billion in cash and 3.10 million in debt, with a net cash position of 1.57 billion or 3.75 per share.

Cash & Cash Equivalents 1.57B
Total Debt 3.10M
Net Cash 1.57B
Net Cash Per Share 3.75
Equity (Book Value) 2.26B
Book Value Per Share 5.41
Working Capital 1.65B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 65.98 million and capital expenditures -87.60 million, giving a free cash flow of -21.61 million.

Operating Cash Flow 65.98M
Capital Expenditures -87.60M
Free Cash Flow -21.61M
FCF Per Share -0.05
Full Cash Flow Statement

Margins

Gross margin is 21.49%, with operating and profit margins of -0.53% and 8.78%.

Gross Margin 21.49%
Operating Margin -0.53%
Pretax Margin 9.51%
Profit Margin 8.78%
EBITDA Margin 5.72%
EBIT Margin -0.53%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 0.17, which amounts to a dividend yield of 1.37%.

Dividend Per Share 0.17
Dividend Yield 1.37%
Dividend Growth (YoY) -47.92%
Years of Dividend Growth n/a
Payout Ratio 190.38%
Buyback Yield -0.56%
Shareholder Yield 0.78%
Earnings Yield 0.71%
FCF Yield -0.41%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on August 27, 2025. It was a forward split with a ratio of 1.45.

Last Split Date Aug 27, 2025
Split Type Forward
Split Ratio 1.45

Scores

SHE:301211 has an Altman Z-Score of 23.54 and a Piotroski F-Score of 3.

Altman Z-Score 23.54
Piotroski F-Score 3